Advertisement

NLS pila pharma

Pharma Business - April 25, 2022

Pila Pharma applies for Orphan Drug Designation in the US

The company has submitted a request for an Orphan Drug Designation to the U.S. Food and Drug Administration (FDA) for the company’s development candidate XEN-D0501. The aim is to develop a novel treatment of a rare disease associated with pain due to neurogenic inflammation. “I’m really pleased, that we can now publically share what we […]

Nobel Prize Discoveries - April 24, 2022

Unlocking the door to a complex sense

The Nobel Laureates in Medicine 2021 revealed the mechanisms that underpin the different sensations of temperature and touch. Their discoveries have led to a better understanding of how the nervous system codes sensory information, as well as triggering a myriad of exciting new questions.

In a new job - February 10, 2022

Pila Pharma announces changes to its organization

Scientific Advisor Henning Beck Nielsen, as well as COO Lars B. Rasmussen have both decided to step out of their current PILA roles to focus more on other projects outside the company. “I, sincerely, thank them both for their tremendous contribution in developing PILA to its current stage. Together with Henning Beck-Nielsen we laid out […]

Uncategorized - October 7, 2021

PILA Pharma’s leading principle awarded with a Nobel Prize

One of the receptors discovered by the Nobel Laureates in Medicine is the TRPV1 receptor, which is used by PILA as the leading principle for a novel treatment of diabetes. The 2021 Nobel prize in Physiology or Medicine honors discoveries of receptors for temperature and touch. One of these receptors, the TRPV1 receptor, is thanks […]

Agreement - August 10, 2021

Pila Pharma signs manufacturing agreement

Pila Pharma has signed a manufacturing agreement with Almac Sciences Limited, UK, for the production of XEN-D0501 active pharmaceutical ingredient (API). The availability of new API is key for conducting the planned 3 month toxicology studies, that are in turn a prerequisite for initiating the clinical phase 2b study in type-2 diabetics, states the company […]

In a new job - May 26, 2021

Pila Pharma announces management changes

The company has announced adjustment to the management team and the appointment of a new Chairman of the Board to prepare for coming upscaling of the company. “I am pleased to share the information that we have promoted Lars Bukhave Rasmussen, to become Chief Operating Officer (COO). Further, I’m proud to announce the appointment of […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.